Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
Kalyan Dulla, Ralph Slijkerman, Hester C. van Diepen, et al.
Molecular Therapy (2021) Vol. 29, Iss. 8, pp. 2441-2455
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Oligonucleotide Therapeutics: From Discovery and Development to Patentability
Lara Moumné, Anne-Céline Marie, Nicolas Crouvezier
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 260-260
Open Access | Times Cited: 103
The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification
Sedigheh Delmaghani, A. Amraoui
Human Genetics (2022) Vol. 141, Iss. 3-4, pp. 709-735
Open Access | Times Cited: 74
Amplifying gene expression with RNA-targeted therapeutics
Olga Khorkova, Jack Stahl, Aswathy Joji, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 539-561
Open Access | Times Cited: 69
Spectrum of Genetic Variants in the Most Common Genes Causing Inherited Retinal Disease in a Large Molecularly Characterized United Kingdom Cohort
Siying Lin, Sandra Vermeirsch, Nikolas Pontikos, et al.
Ophthalmology Retina (2024) Vol. 8, Iss. 7, pp. 699-709
Open Access | Times Cited: 16
Unveiling Sequence-Agnostic Mixed-Chemical Modification Patterns for Splice-Switching Oligonucleotides using the NATURA platform
Tommaso Tabaglio, Taniya Agarwal, Wei Yuan Cher, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102422-102422
Open Access | Times Cited: 2
A look into retinal organoids: methods, analytical techniques, and applications
Tess A. V. Afanasyeva, Julio C. Corral-Serrano, Alejandro Garanto, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 19-20, pp. 6505-6532
Open Access | Times Cited: 71
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
Hironori Adachi, Martin Hengesbach, Yi‐Tao Yu, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 550-550
Open Access | Times Cited: 58
RNA-based therapeutics for neurological diseases
Karen Anthony
RNA Biology (2022) Vol. 19, Iss. 1, pp. 176-190
Open Access | Times Cited: 57
Gene-Based Therapeutics for Inherited Retinal Diseases
Beau J. Fenner, Tien‐En Tan, Veluchamy A. Barathi, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 45
Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy
Marianthi Karali, Francesco Testa, Valentina Di Iorio, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Cellular and Molecular Mechanisms of Pathogenesis Underlying Inherited Retinal Dystrophies
Andrew Manley, Bahar I. Meshkat, Monica M. Jablonski, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 271-271
Open Access | Times Cited: 23
Next generation therapeutics for retinal neurodegenerative diseases
Matthew B. Appell, Jahnavi Pejavar, Ashwin Pasupathy, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 708-736
Closed Access | Times Cited: 11
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity
Marzena Kurzawa‐Akanbi, Nikolaos Tzoumas, Julio C. Corral-Serrano, et al.
Progress in Retinal and Eye Research (2024) Vol. 100, pp. 101248-101248
Open Access | Times Cited: 11
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
RNA-targeting strategies as a platform for ocular gene therapy
Satheesh Kumar, Lewis E. Fry, Jiang-Hui Wang, et al.
Progress in Retinal and Eye Research (2022) Vol. 92, pp. 101110-101110
Closed Access | Times Cited: 30
Current and Future Treatment of Retinitis Pigmentosa
Nancy E. Cross, Cécile van Steen, Yasmina Zegaoui, et al.
Clinical ophthalmology (2022) Vol. Volume 16, pp. 2909-2921
Open Access | Times Cited: 28
Antisense oligonucleotide therapy corrects splicing in the common Stargardt disease type 1-causing variant ABCA4 c.5461-10T>C
Melita Kaltak, Petra de Bruijn, Davide Piccolo, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 674-688
Open Access | Times Cited: 21
Whole genome sequencing for USH2A-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction
Janine Reurink, Nicole Weisschuh, Alejandro Garanto, et al.
Human Genetics and Genomics Advances (2023) Vol. 4, Iss. 2, pp. 100181-100181
Open Access | Times Cited: 17
Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2
Merel Stemerdink, Belén García‐Bohórquez, Renske Schellens, et al.
Human Genetics (2021) Vol. 141, Iss. 3-4, pp. 737-758
Closed Access | Times Cited: 33
USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids
Carla Sanjurjo-Soriano, Carla Jimenez-Medina, Nejla Erkilic, et al.
Human Genetics and Genomics Advances (2023) Vol. 4, Iss. 4, pp. 100229-100229
Open Access | Times Cited: 13
A Genomic Analysis of Usher Syndrome: Population-Scale Prevalence and Therapeutic Targets
Shelby Redfield, Stéphanie A. Mauriac, Gwenaëlle S. G. Géléoc, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
RNA-based therapies in inherited retinal diseases
Aniz Girach, Isabelle Audo, David G. Birch, et al.
Therapeutic Advances in Ophthalmology (2022) Vol. 14, pp. 251584142211346-251584142211346
Open Access | Times Cited: 21
Zebrafish and inherited photoreceptor disease: Models and insights
Nicole C. L. Noel, W. Ted Allison, Ian M. MacDonald, et al.
Progress in Retinal and Eye Research (2022) Vol. 91, pp. 101096-101096
Open Access | Times Cited: 19
Successful large gene augmentation of USH2A with non-viral episomal vectors
Maria Toms, Lyes Toualbi, Patrick Almeida, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2755-2766
Open Access | Times Cited: 12
Leveraging high-throughput screening technologies in targeted mRNA delivery
Yuchen Zhang, Zhifei Gao, Xiao Yang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101101-101101
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top